Ekso Bionics (EKSO) Stock Forecast, Price & News

Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

Is Ekso Bionics a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Ekso Bionics stock.
View analyst ratings for Ekso Bionics or view top-rated stocks.

When is Ekso Bionics' next earnings date?

Ekso Bionics is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Ekso Bionics.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) issued its earnings results on Thursday, April, 28th. The company reported ($0.36) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.41) by $0.05. Ekso Bionics had a negative trailing twelve-month return on equity of 33.87% and a negative net margin of 90.01%. During the same period in the previous year, the firm earned ($0.34) earnings per share.
View Ekso Bionics' earnings history.

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Shares of Ekso Bionics reverse split on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

What price target have analysts set for EKSO?

1 brokerages have issued 12 month target prices for Ekso Bionics' shares. Their forecasts range from $11.00 to $11.00. On average, they anticipate Ekso Bionics' share price to reach $11.00 in the next twelve months. This suggests a possible upside of 497.8% from the stock's current price.
View analysts' price targets for Ekso Bionics or view top-rated stocks among Wall Street analysts.

Who are Ekso Bionics' key executives?

Ekso Bionics' management team includes the following people:

• Mr. Steven A. Sherman, Chairman & CEO (Age 76, Pay $100k)
• Mr. John F. Glenn, CFO & Sec. (Age 60, Pay $332k)
• Mr. William R. Shaw, Consultant (Age 47, Pay $402.14k)
• Mr. Scott W. Davis, Pres & COO
• Ms. Rachael Anderson, Global Director of Marketing & Strategic Growth
• Mr. Anthony Pratt, US Director of Sales
• Ms. Foon Lim Chwee, Pres of APAC
• Mr. Jerome Wong, Corp. Controller

Who are some of Ekso Bionics' key competitors?

Some companies that are related to Ekso Bionics include Taylor Devices (TAYD), International Baler (IBAL), RINO International (RINO), Integrated Environmental Technologies (IEVM), China Energy Recovery (CGYV) and Reelcause (RCIT).
View all of EKSO's competitors.

What other stocks do shareholders of Ekso Bionics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ekso Bionics investors own include OrganiGram (OGI), Gran Tierra Energy (GTE), KushCo (KSHB), CNBX Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Bionano Genomics (BNGO), Novan (NOVN), Pennsylvania Real Estate Investment Trust (PEI) and ADMA Biologics (ADMA).

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

Who are Ekso Bionics' major shareholders?

Ekso Bionics' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.43%), Essex Investment Management Co. LLC (1.31%), Renaissance Technologies LLC (0.14%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Company insiders that own Ekso Bionics stock include Jason C Jones, John Glenn, Scott G Davis and Steven Sherman.
View institutional ownership trends for Ekso Bionics.

Which major investors are selling Ekso Bionics stock?

EKSO stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Vanguard Group Inc., and Simplex Trading LLC. Company insiders that have sold Ekso Bionics company stock in the last year include Jason C Jones, John Glenn, Scott G Davis, and Steven Sherman.
View insider buying and selling activity for Ekso Bionics or view top insider-selling stocks.

Which major investors are buying Ekso Bionics stock?

EKSO stock was bought by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC.
View insider buying and selling activity for Ekso Bionics or or view top insider-buying stocks.

How do I buy shares of Ekso Bionics?

Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $1.84.

How much money does Ekso Bionics make?

Ekso Bionics has a market capitalization of $23.63 million and generates $11.25 million in revenue each year. The company earns $-9.76 million in net income (profit) each year or ($0.870010) on an earnings per share basis.

How many employees does Ekso Bionics have?

Ekso Bionics employs 55 workers across the globe.

What is Ekso Bionics' official website?

The official website for Ekso Bionics is www.eksobionics.com.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at (510) 984-1761, via email at [email protected], or via fax at 510-927-2647.